• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia].

作者信息

Solary E, Witz F, Moreau P, Quiquandon I, Genne P, Flesch M, Saddoun A, Maloisel F, Pignon B, Abgrall J F

机构信息

Hématologie Clinique, CHU Le Bocage, Dijon, France.

出版信息

Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S141-3.

PMID:7971263
Abstract
摘要

相似文献

1
[Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia].米托蒽醌联合阿糖胞苷加或不加奎宁治疗难治性或复发性急性白血病
Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S141-3.
2
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.大剂量与中剂量阿糖胞苷联合米托蒽醌治疗复发难治性急性髓系白血病：一项年龄校正随机对照研究结果
Semin Hematol. 1991 Jul;28(3 Suppl 4):35-8.
3
A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.卡铂、大剂量阿糖胞苷与交替使用米托蒽醌或伊达比星的新联合方案治疗难治性和复发性急性髓系白血病。
Haematologica. 1998 May;83(5):422-7.
4
[Preliminary treatment results of relapsed or refractory acute leukemia using two and three drug regimens].[采用两药和三药方案治疗复发或难治性急性白血病的初步治疗结果]
Wiad Lek. 1998;51(1-2):42-5.
5
[Intermediate-dose cytosine arabinoside in combination with mitoxantrone in the treatment of refractory leukemia].
Rinsho Ketsueki. 1988 Jul;29(7):1050-4.
6
Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.米托蒽醌与阿糖胞苷诱导、大剂量阿糖胞苷以及依托泊苷强化治疗复发或难治性急性髓系白血病儿童患者：儿童癌症研究组2951研究
J Clin Oncol. 2003 Aug 1;21(15):2940-7. doi: 10.1200/JCO.2003.06.128.
7
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.米托蒽醌、依托泊苷、阿糖胞苷联合环孢素治疗复发或难治性急性髓系白血病：东部肿瘤协作组的一项试点研究。
Cancer. 1999 Jan 15;85(2):358-67.
8
Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.克拉屈滨联合大剂量阿糖胞苷、米托蒽醌和粒细胞集落刺激因子（CLAG-M）是一种治疗预后不良的难治性和复发性急性髓系白血病患者的高效挽救方案：波兰成人白血病组的最终报告
Eur J Haematol. 2008 Feb;80(2):115-26. doi: 10.1111/j.1600-0609.2007.00988.x. Epub 2007 Dec 11.
9
Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.单剂量米托蒽醌联合持续输注中剂量阿糖胞苷加依托泊苷治疗难治性或早期复发的急性髓系白血病。
Leuk Res. 2009 Apr;33(4):511-7. doi: 10.1016/j.leukres.2008.08.009. Epub 2008 Sep 25.
10
Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.成人原发性难治性或复发性急性髓系白血病的序贯化疗：II期Gemia方案的结果
Haematologica. 1999 Mar;84(3):226-30.